Cite
HARVARD Citation
Beck, M. et al. (2017). Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings?. European journal of hospital pharmacy. 24 (2), pp. 85-90. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Beck, M. et al. (2017). Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings?. European journal of hospital pharmacy. 24 (2), pp. 85-90. [Online].